NCT05494671

Brief Summary

Integrity of the corneal epithelium is the function of intact limbal stem cells. The reduction in the population of LSCs and their dysfunction result in abnormal corneal epithelialization and invasion of the corneal surface by the conjunctival epithelium with or without corneal neovascularization that is, limbal stem cell deficiency (LSCD). Different techniques have been developed to treat cases of limbal stem cell deficiency due to traumatic or congenital cases. Recent innovations developed to predict the early stages of stem cell deficiency. One of these methods is measurement of the central epithelial thickness as it was found that limbal stem cell deficiency causes reduction of the central epithelial thickness. The aim of this study is to study changes in the corneal epithelial thickness at different quadrants of the cornea to observe the exact time of epithelial stability following stem cell transplantation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 7, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 10, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

August 7, 2022

Last Update Submit

August 29, 2023

Conditions

Keywords

stem cell transplantation,stem cell deficiencyCLAU

Outcome Measures

Primary Outcomes (1)

  • the change of corneal epithelial thickness after stem cell transplantation over 9 months

    Corneal epithelial mapping will be done at one month, 3,6 and 9 months in both the donated and the recipient eyes using anterior segment OCT at the center

    9 months

Study Arms (1)

conjunctival limbal autologous transplant

EXPERIMENTAL

patients with unilateral stem cell deficiency due to chemical burn

Procedure: conjunctival limbal autologous transplant

Interventions

Patients with unilateral chemical ocular injury will be included in the study. All selected patients will receive a thorough explanation of the study design and aims and informed consent will be obtained in all patients. Eyes of all participants will be subjected to: Best corrected visual acuity, Slit lamp examination and ocular ultrasound if no fundus view. Staging of degree of limbal stem cell deficiency is done by Roper Hall classification and then the patient will have conjunctival limbal autologous transplant (CLAU)

conjunctival limbal autologous transplant

Eligibility Criteria

Age15 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 15 to 70 years
  • Unilateral limbal stem cell deficiency
  • Grade 4 stem cell deficiency

You may not qualify if:

  • Cases with extensive symblepharon
  • Cases with very poor visual acuity ( no light perception)
  • Cases with posterior segment problem evident in ocular ultrasonography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alainy

Cairo, 11562, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: interventional case series
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

August 7, 2022

First Posted

August 10, 2022

Study Start

January 1, 2022

Primary Completion

January 10, 2023

Study Completion

November 1, 2023

Last Updated

August 30, 2023

Record last verified: 2023-08

Locations